These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Structural studies of new macrolide antibiotics, shurimycins A and B. Kumazawa S; Asami Y; Awane K; Ohtani H; Fukuchi C; Mikawa T; Hayase T J Antibiot (Tokyo); 1994 Jun; 47(6):688-96. PubMed ID: 8040074 [TBL] [Abstract][Full Text] [Related]
24. Ripromycin and other polycyclic macrolactams from Streptomyces sp. Tü 6239: taxonomy, fermentation, isolation and biological properties. Bertasso M; Holzenkämpfer M; Zeeck A; Stackebrandt E; Beil W; Fiedler HP J Antibiot (Tokyo); 2003 Apr; 56(4):364-71. PubMed ID: 12817810 [TBL] [Abstract][Full Text] [Related]
25. Aldgamycin I, an antibacterial 16-membered macrolide from the abandoned mine bacterium, Streptomyces sp. KMA-001. Park JS; Yang HO; Kwon HC J Antibiot (Tokyo); 2009 Mar; 62(3):171-5. PubMed ID: 19218982 [No Abstract] [Full Text] [Related]
26. Albidopyrone, a new alpha-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227. Hohmann C; Schneider K; Bruntner C; Brown R; Jones AL; Goodfellow M; Krämer M; Imhoff JF; Nicholson G; Fiedler HP; Süssmuth RD J Antibiot (Tokyo); 2009 Feb; 62(2):75-9. PubMed ID: 19132055 [TBL] [Abstract][Full Text] [Related]
27. New beauveriolides produced by amino acid-supplemented fermentation of Beauveria sp. FO-6979. Matsuda D; Namatame I; Tomoda H; Kobayashi S; Zocher R; Kleinkauf H; Omura S J Antibiot (Tokyo); 2004 Jan; 57(1):1-9. PubMed ID: 15032479 [TBL] [Abstract][Full Text] [Related]
28. Tripropeptin E, a new tripropeptin group antibiotic produced by Lysobacter sp. BMK333-48F3. Hashizume H; Hattori S; Igarashi M; Akamatsu Y J Antibiot (Tokyo); 2004 Jun; 57(6):394-9. PubMed ID: 15323129 [No Abstract] [Full Text] [Related]
29. Two new members of streptothricin class antibiotics from Streptomyces qinlingensis sp. nov. Ji Z; Wang M; Zhang J; Wei S; Wu W J Antibiot (Tokyo); 2007 Dec; 60(12):739-44. PubMed ID: 18276997 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic GE37468 A: a novel inhibitor of bacterial protein synthesis. II. Structure elucidation. Ferrari P; Colombo L; Stella S; Selva E; Zerilli LF J Antibiot (Tokyo); 1995 Nov; 48(11):1304-11. PubMed ID: 8557573 [TBL] [Abstract][Full Text] [Related]
32. Fusaricidin A, a new depsipeptide antibiotic produced by Bacillus polymyxa KT-8. Taxonomy, fermentation, isolation, structure elucidation and biological activity. Kajimura Y; Kaneda M J Antibiot (Tokyo); 1996 Feb; 49(2):129-35. PubMed ID: 8621351 [TBL] [Abstract][Full Text] [Related]
33. Phenatic acids A and B, new potentiators of antifungal miconazole activity produced by Streptomyces sp. K03-0132. Fukuda T; Matsumoto A; Takahashi Y; Tomoda H; Omura S J Antibiot (Tokyo); 2005 Apr; 58(4):252-9. PubMed ID: 15981411 [TBL] [Abstract][Full Text] [Related]
34. Cyclothiazomycin, a novel polythiazole-containing peptide with renin inhibitory activity. Taxonomy, fermentation, isolation and physico-chemical characterization. Aoki M; Ohtsuka T; Yamada M; Ohba Y; Yoshizaki H; Yasuno H; Sano T; Watanabe J; Yokose K; Seto H J Antibiot (Tokyo); 1991 Jun; 44(6):582-8. PubMed ID: 2071486 [TBL] [Abstract][Full Text] [Related]
35. Isolation of a novel cyclic hexadepsipeptide pipalamycin from Streptomyces as an apoptosis-inducing agent. Uchihata Y; Ando N; Ikeda Y; Kondo S; Hamada M; Umezawa K J Antibiot (Tokyo); 2002 Jan; 55(1):1-5. PubMed ID: 11918058 [TBL] [Abstract][Full Text] [Related]
36. Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp. Igarashi M; Sawa R; Kinoshita N; Hashizume H; Nakagawa N; Homma Y; Nishimura Y; Akamatsu Y J Antibiot (Tokyo); 2008 Jun; 61(6):387-93. PubMed ID: 18667787 [TBL] [Abstract][Full Text] [Related]
37. L-681,217, a new and novel member of the efrotomycin family of antibiotics. Kempf AJ; Wilson KE; Hensens OD; Monaghan RL; Zimmerman SB; Dulaney EL J Antibiot (Tokyo); 1986 Oct; 39(10):1361-7. PubMed ID: 3781906 [TBL] [Abstract][Full Text] [Related]
38. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities. Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Suzuki M; Onodera H; Tomoda H; Matsui H; Hanaki H; Iwatsuki M; Ōmura S; Shiomi K J Antibiot (Tokyo); 2017 May; 70(5):562-567. PubMed ID: 28293038 [TBL] [Abstract][Full Text] [Related]
39. Novel antibiotics, amythiamicins. I. Taxonomy, fermentation, isolation, physico-chemical properties, and antimicrobial activity. Shimanaka K; Kinoshita N; Iinuma H; Hamada M; Takeuchi T J Antibiot (Tokyo); 1994 Jun; 47(6):668-74. PubMed ID: 8040071 [TBL] [Abstract][Full Text] [Related]
40. A new cyclic lipopeptide antibiotic, enamidonin. Koshino S; Koshino H; Matsuura N; Kobinata K; Onose R; Isono K; Osada H J Antibiot (Tokyo); 1995 Feb; 48(2):185-7. PubMed ID: 7706133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]